Govt Job: For Pharmacology, Life Sciences Job as Editorial Assistant at PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab, and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India, Pt. Jawahar Lal Nehru, who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Post : Editorial Assistant (One Post)

Applications are invited on a plain paper for the contractual post of Editorial Assistant in International Journal of Pharmaceutical Sciences and Nanotechnology (IJPSN) by Professor Bikash Medhi, Chief Editor, Department of Pharmacology, PGIMER, Chandigarh-160012. The post is purely on temporary basis.

Qualification :First Class Master’s Degree in Pharmacology / Life-Sciences from a recognized university.

Desirable : Experience in the Research field or scientific writing. Candidates with proficiency in computer application will be preferred

Age : As per GOI rules
Pay Scale : Rs. 35, 000/- per month (consolidated).

The above appointment will be purely on temporary basis. Interested candidates fulfilling the above conditions are required to submit their bio-data and necessary testimonials/ certificates by 6th May, 2022, through email at recruitmentmanpowereplpgimer@gmail.com

The candidates will be scrutinized by the selection committee and only short-listed candidates will be intimated through email/phone to attend the interview through online mode. No Separate interview letters will be sent.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit